Kestra Advisory Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Sell
2,102
-175
-8% -$36.3K ﹤0.01% 2489
2026
Q1
$511K Buy
2,277
+606
+36% +$151K ﹤0.01% 2205
2025
Q4
$403K Sell
1,671
-46
-3% -$11.8K ﹤0.01% 2316
2025
Q3
$470K Sell
1,717
-414
-19% -$113K ﹤0.01% 2107
2025
Q2
$550K Sell
2,131
-363
-15% -$86.6K ﹤0.01% 1899
2025
Q1
$558K Sell
2,494
-2,445
-50% -$571K ﹤0.01% 1757
2024
Q4
$1.13M Buy
4,939
+118
+2% +$28.4K 0.01% 1343
2024
Q3
$1.18M Sell
4,821
-504
-9% -$113K 0.01% 1234
2024
Q2
$901K Buy
5,325
+3,437
+182% +$697K 0.01% 1384
2024
Q1
$374K Sell
1,888
-1,771
-48% -$325K ﹤0.01% 1852
2023
Q4
$630K Buy
3,659
+1,873
+105% +$288K 0.01% 1390
2023
Q3
$264K Buy
1,786
+15
+0.8% +$2.71K ﹤0.01% 1751
2023
Q2
$387K Buy
1,771
+153
+9% +$34.1K ﹤0.01% 1449
2023
Q1
$354K Sell
1,618
-2,388
-60% -$518K ﹤0.01% 1468
2022
Q4
$834K Buy
4,006
+1,150
+40% +$253K 0.01% 1143
2022
Q3
$624K Sell
2,856
-3,152
-52% -$717K 0.01% 1196
2022
Q2
$1.26M Buy
6,008
+3,631
+153% +$773K 0.01% 863
2022
Q1
$576K Buy
2,377
+73
+3% +$17.7K 0.01% 1209
2021
Q4
$600K Sell
2,304
-44
-2% -$11.4K 0.01% 1220
2021
Q3
$619K Sell
2,348
-8
-0.3% -$2.19K 0.01% 1274
2021
Q2
$581K Buy
2,356
+31
+1% +$6.52K 0.01% 1214
2021
Q1
$451K Sell
2,325
-25
-1% -$5.01K 0.01% 1248
2020
Q4
$493K Buy
2,350
+2,329
+11,090% +$464K 0.01% 1217
2020
Q3
$306K Buy
+21
New +$3.88K 0.01% 1103

Other funds holding RMD

Kestra Advisory Services's RMD Position: Q2 2026 in Review

Kestra Advisory Services reduced its ResMed (RMD) stake by 7.7% in Q2 2026, selling an estimated $36.3K and leaving 2,102 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2489.

Kestra Advisory Services first reported a position in RMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.26M in Q2 2022. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Kestra Advisory Services held 2,102 shares of ResMed worth $410K as of Q2 2026.
  • Kestra Advisory Services sold 175 ResMed shares in Q2 2026, an estimated $36.3K.
  • ResMed made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2489 holding.
  • Kestra Advisory Services first reported a position in ResMed in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's ResMed position peaked at $1.26M in Q2 2022.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.